whether EVERY patient with type 2 diabetes should take an ACE inhibitor or ARB, aspirin, and statin

November 2012

You'll hear controversy over whether EVERY patient with type 2 diabetes should take an ACE inhibitor or ARB, aspirin, and statin.

This push is partly due to insurer pay-for-performance programs.

These drugs are often helpful...but watch for the exceptions.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote